4 completed, 2 not yet recruiting, 1 recruiting. 3 Phase 2, 2 Phase 1, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Hangzhou PhecdaMed Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease TJ0113 200mg, TJ0113 400mg, Placebo - Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset | Phase 3 | Not yet recruiting | Hangzhou PhecdaMed Co., Ltd. | 300 | 2026-08-03 | 2026-08-12 |
| Clinical Study of TJ0113 Capsule in the Treatment of Patients With Sarcopenia TJ0113, Placebo - Sarcopenia | Phase 2 | Recruiting | Hangzhou PhecdaMed Co., Ltd. | 204 | 2026-06-12 | 2026-08-05 |
| Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive Disorder TJ0113, Placebo - Depression | Phase 2 | Completed | Hangzhou PhecdaMed Co., Ltd. | 149 | 2025-07-09 | 2026-08-25 |
| A Clinical Trial of the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss TJ0113 capsules, Placebo capsules - Age Related Hearing Loss, Deafness | Not applicable | Not yet recruiting | Yilai Shu | 60 | 2025-06-07 | 2025-06-10 |
| Mass Balance Study of [14C] TJ0113 in Healthy Chinese Subjects [14C]TJ0113 - Healthy Chinese Subjects | Phase 1 | Completed | Hangzhou PhecdaMed Co., Ltd. | 6 | 2025-02-19 | 2025-11-17 |
| Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease TJ0113 200mg, TJ0113 400mg, Placebo - Parkinson Disease | Phase 2 | Completed | Second Affiliated Hospital, Zhejiang University, School of Medicine | 149 | 2024-09-18 | 2026-01-16 |
| Single Ascending Dose Study(SAD),Multiple Ascending Dose Study(MAD) , High-fat Diet Study (FE) of TJ0113 Capsules in Healthy Subjects TJ0113 Capsules, Placebo - Healthy Subjects | Phase 1 | Completed | Hangzhou PhecdaMed Co., Ltd. | 130 | 2023-08-04 | 2026-02-06 |
Parkinson Disease (2) · Deafness (1) · Depression (1) · Parkinson Disease 6, Autosomal Recessive Early-Onset (1) · Presbycusis (1) · Sarcopenia (1)
China (7)
Jian Chen (1) · Qin Zhang (1) · Shaohua Hu (1) · Wei Luo, Doctor (1)